Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefanía Moreno, Clara Andradas, Mireia Medrano, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 32, pp. 21960-21972
Open Access | Times Cited: 105

Showing 26-50 of 105 citing articles:

The Emerging Role of Adhesion GPCRs in Cancer
Abanoub A. Gad, Nariman Balenga
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 1, pp. 29-42
Open Access | Times Cited: 55
The Interplay between the Immune and the Endocannabinoid Systems in Cancer
Mariantonia Braile, Simone Marcella, Gianni Marone, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1282-1282
Open Access | Times Cited: 42
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
Esther Martínez-Martínez, Asunción Martín-Ruiz, Paloma Martín, et al.
Oncotarget (2016) Vol. 7, Iss. 42, pp. 68781-68791
Open Access | Times Cited: 54
In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy
Lucía Martín‐Banderas, I. Muñoz-Rubio, José Prados, et al.
International Journal of Pharmaceutics (2015) Vol. 487, Iss. 1-2, pp. 205-212
Closed Access | Times Cited: 51
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Sandra Blasco-Benito, Estefanía Moreno, Marta Seijo-Vila, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 9, pp. 3863-3872
Open Access | Times Cited: 51
Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists
Rafael Franco, Irene Reyes‐Resina, David Aguinaga, et al.
Glia (2019) Vol. 67, Iss. 12, pp. 2410-2423
Closed Access | Times Cited: 47
Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development?
Diego Guidolin, Manuela Marcoli, Cinzia Tortorella, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 43
Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB 1 /CB 2 versus GPR55 receptors
Xiao‐Fei Wang, Ewa Galaj, Guo‐Hua Bi, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 8, pp. 1865-1880
Open Access | Times Cited: 43
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival
Livio Casarini, Clara Lazzaretti, Elia Paradiso, et al.
iScience (2020) Vol. 23, Iss. 12, pp. 101812-101812
Open Access | Times Cited: 41
Roles of G protein-coupled receptors in inflammatory bowel disease
Zhen Zeng, Arjudeb Mukherjee, Adwin Pidiyath Varghese, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 12, pp. 1242-1261
Open Access | Times Cited: 39
Two-Step Cell Death Induction by the New 2-Arachidonoyl Glycerol Analog and Its Modulation by Lysophosphatidylinositol in Human Breast Cancer Cells
Mikhail Akimov, N. M. Gretskaya, Evgenia I. Gorbacheva, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 820-820
Open Access
In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling
Kawthar A. Mohamed, Robert B. Laprairie
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 2
Open Access
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
Elena Ciaglia, Giovanni Torelli, Simona Pisanti, et al.
Oncotarget (2015) Vol. 6, Iss. 17, pp. 15464-15481
Open Access | Times Cited: 46
Targeting the endocannabinoid system as a potential anticancer approach
Rico Schwarz, Robert Ramer, Burkhard Hinz
Drug Metabolism Reviews (2018) Vol. 50, Iss. 1, pp. 26-53
Closed Access | Times Cited: 46
G-protein-coupled receptor type A heteromers as an emerging therapeutic target
Diego Guidolin, Luigi F. Agnati, Manuela Marcoli, et al.
Expert Opinion on Therapeutic Targets (2014) Vol. 19, Iss. 2, pp. 265-283
Closed Access | Times Cited: 43
Antitumorigenic targets of cannabinoids – current status and implications
Robert Ramer, Burkhard Hinz
Expert Opinion on Therapeutic Targets (2016) Vol. 20, Iss. 10, pp. 1219-1235
Closed Access | Times Cited: 40
Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers
Silvia L. Cruz, Elizabeth Sánchez-Miranda, Jorge Iván Castillo-Arellano, et al.
International Immunopharmacology (2018) Vol. 64, pp. 298-307
Closed Access | Times Cited: 38
Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway
Yang Yang, Nhi Huynh, Chelsea Dumesny, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8035-8035
Open Access | Times Cited: 34
Therapeutic potential of cannabinoids in combination cancer therapy
Pratibha Malhotra, Ilaria Casari, Marco Falasca
Advances in Biological Regulation (2021) Vol. 79, pp. 100774-100774
Closed Access | Times Cited: 27
The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling
Argelia Calvillo-Robledo, Rodolfo Daniel Cervantes‐Villagrana, Paula Morales, et al.
Life Sciences (2022) Vol. 301, pp. 120596-120596
Open Access | Times Cited: 19
Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer
Raphaël Jorand, Sunetra Biswas, Devin L. Wakefield, et al.
Molecular Biology of the Cell (2016) Vol. 27, Iss. 22, pp. 3659-3672
Open Access | Times Cited: 33
Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor
Silvia Marino, Aymen I. Idris
Pharmacological Research (2017) Vol. 119, pp. 391-403
Open Access | Times Cited: 33
The endocannabinoid system is modulated in reward and homeostatic brain regions following diet-induced obesity in rats: a cluster analysis approach
Romain Bourdy, Alexandra Hertz, Dominique Filliol, et al.
European Journal of Nutrition (2021) Vol. 60, Iss. 8, pp. 4621-4633
Open Access | Times Cited: 26
Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract
Jerome Lian, Ilaria Casari, Marco Falasca
Pharmacological Research (2021) Vol. 175, pp. 106025-106025
Closed Access | Times Cited: 26

Scroll to top